These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27670974)

  • 1. Effect of piperine on CYP2E1 enzyme activity of chlorzoxazone in healthy volunteers.
    Bedada SK; Boga PK
    Xenobiotica; 2017 Dec; 47(12):1035-1041. PubMed ID: 27670974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol Pretreatment Affects CYP2E1 Activity of Chlorzoxazone in Healthy Human Volunteers.
    Bedada SK; Neerati P
    Phytother Res; 2016 Mar; 30(3):463-8. PubMed ID: 26680654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of quercetin on the pharmacokinetics of chlorzoxazone, a CYP2E1 substrate, in healthy subjects.
    Bedada SK; Neerati P
    Eur J Clin Pharmacol; 2018 Jan; 74(1):91-97. PubMed ID: 28983678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on influence of piperine treatment on the pharmacokinetics of diclofenac in healthy volunteers.
    Bedada SK; Boga PK; Kotakonda HK
    Xenobiotica; 2017 Feb; 47(2):127-132. PubMed ID: 27052193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Piperine on the Metabolism and Pharmacokinetics of Carbamazepine in Healthy Volunteers.
    Bedada SK; Appani R; Boga PK
    Drug Res (Stuttg); 2017 Jan; 67(1):46-51. PubMed ID: 27776366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study on the pharmacokinetics of chlorzoxazone in healthy Thai volunteers.
    Prompila N; Wittayalertpanya S; Komolmit P
    J Med Assoc Thai; 2007 Jan; 90(1):160-6. PubMed ID: 17621748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of piperine on the pharmacokinetics of fexofenadine, a P-glycoprotein substrate, in healthy volunteers.
    Bedada SK; Boga PK
    Eur J Clin Pharmacol; 2017 Mar; 73(3):343-349. PubMed ID: 27981349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of piperine on the bioavailability and pharmacokinetics of rosmarinic acid in rat plasma using UPLC-MS/MS.
    Yang JH; Mao KJ; Huang P; Ye YJ; Guo HS; Cai BC
    Xenobiotica; 2018 Feb; 48(2):178-185. PubMed ID: 28669317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of CYP2E1 by chlormethiazole as measured by chlorzoxazone pharmacokinetics in patients with alcoholism and in healthy volunteers.
    Eap CB; Schnyder C; Besson J; Savary L; Buclin T
    Clin Pharmacol Ther; 1998 Jul; 64(1):52-7. PubMed ID: 9695719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic cytochrome P450 2E1 activity in nonalcoholic fatty liver disease.
    Prompila N; Wittayalertpanya S; Komolmit P
    J Med Assoc Thai; 2008 May; 91(5):733-8. PubMed ID: 18672640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of piperine, a major component of black pepper, on the pharmacokinetics of domperidone in rats.
    Alhumayyd MS; Bukhari IA; Almotrefi AA
    J Physiol Pharmacol; 2014 Dec; 65(6):785-9. PubMed ID: 25554982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo CYP2E1 phenotyping as a new potential biomarker of occupational and experimental exposure to benzene.
    Piccoli P; Carrieri M; Padovano L; Di Mare M; Bartolucci GB; Fracasso ME; Lepera JS; Manno M
    Toxicol Lett; 2010 Jan; 192(1):29-33. PubMed ID: 19900514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired 6-hydroxychlorzoxazone elimination in patients with kidney disease: Implication for cytochrome P450 2E1 pharmacogenetic studies.
    Nolin TD; Gastonguay MR; Bies RR; Matzke GR; Frye RF
    Clin Pharmacol Ther; 2003 Dec; 74(6):555-68. PubMed ID: 14663458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An interaction between the cytochrome P450 probe substrates chlorzoxazone (CYP2E1) and midazolam (CYP3A).
    Palmer JL; Scott RJ; Gibson A; Dickins M; Pleasance S
    Br J Clin Pharmacol; 2001 Nov; 52(5):555-61. PubMed ID: 11736864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary excretion of 6-hydroxychlorzoxazone as an index of CYP2E1 activity.
    Dreisbach AW; Ferencz N; Hopkins NE; Fuentes MG; Rege AB; George WJ; Lertora JJ
    Clin Pharmacol Ther; 1995 Nov; 58(5):498-505. PubMed ID: 7586943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circadian rhythm of cytochrome P4502E1 and its effect on disposition kinetics of chlorzoxazone in rats.
    Khemawoot P; Nishino K; Ishizaki J; Yokogawa K; Miyamoto K
    Eur J Pharmacol; 2007 Nov; 574(1):71-6. PubMed ID: 17651723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robustness of chlorzoxazone as an in vivo measure of cytochrome P450 2E1 activity.
    Ernstgård L; Warholm M; Johanson G
    Br J Clin Pharmacol; 2004 Aug; 58(2):190-200. PubMed ID: 15255802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlorzoxazone, a selective probe for phenotyping CYP2E1 in humans.
    Lucas D; Ferrara R; Gonzalez E; Bodenez P; Albores A; Manno M; Berthou F
    Pharmacogenetics; 1999 Jun; 9(3):377-88. PubMed ID: 10471070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotype distribution and gender-related differences of CYP2E1 activity in a Chinese population.
    Chen XP; Han XM; Jiang CH; Huang SL; Liu ZQ; Zhu B; Zhou G; Zhou HH
    Xenobiotica; 2002 Nov; 32(11):1053-62. PubMed ID: 12487734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of resveratrol on the pharmacokinetics of carbamazepine in healthy human volunteers.
    Bedada SK; Nearati P
    Phytother Res; 2015 May; 29(5):701-6. PubMed ID: 25624269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.